Our Blog – What moves us

10 Years Nagoya Protocol

10 Years Nagoya Protocol

New White Paper from IP2 It took 12 years from the first declaration of intent on the protection of genetic resources and indigenous knowledge, the so-called "Rio Convention" of 1992, until the Nagoya Protocol was adopted as a binding agreement under international...

mehr lesen
22 years: bäng-dänge-däng-däng

22 years: bäng-dänge-däng-däng

... this is how a short sequence from the piece "Metall auf Metall" (metal on metal), which can be found on the album "Trans Europa Express" by the German band Kraftwerk from 1977, can be described.  And it is precisely this beat, lasting just 2 seconds, that is at...

mehr lesen
What the expert knows…

What the expert knows…

In a recently published decision (1), the German Federal Court of Justice (BGH) once again addressed the issue of the role of the knowledge of a person skilled in the art in the assessment of inventive step. This provides an opportunity to examine this question...

mehr lesen
G 2/21: The Desaster failed

G 2/21: The Desaster failed

After almost two years of waiting, the Enlarged Board of Appeal published their long-awaited - some would say feared - decision G 2/21 on March 23, 2023 (1). In a nut shell: the disaster fails. But in detail: What is it about? Briefly, about the question of the...

mehr lesen
Biting the Bullet

Biting the Bullet

With around 482.2 billion U.S. dollars, Apple will be the world's most valuable brand by brand value in 2022, according to the Best Global Brands ranking. In the ranking compiled by Interbrand, Microsoft only came in second place with more than 278 billion U.S....

mehr lesen
Sunrise Period for the Unitary Patent started

Sunrise Period for the Unitary Patent started

On March 1, 2023, the sunrise period began, the 3-month phase before the start of the Unitary Patent and the Unified Patent Court on June 1, 2023. From now on, it is possible to file opt-out requests and thus exclude the jurisdiction of the UPC for existing EP...

mehr lesen
Ip2 White Paper on German Employee Inventor Law

Ip2 White Paper on German Employee Inventor Law

Another pitfall for companies from abroad Amid all the enthusiasm about a successful innovation, it is easy to forget that every invention also involves at least one inventor. Even if circumstances differ greatly from country to country, inventors are entitled to...

mehr lesen
ECJ: No chains for green biotechnology

ECJ: No chains for green biotechnology

In its ruling C 688-23 of today (1) the European Court of Justice decided that Genetically Modified Organisms (GMOs) produced by in vitro mutagenesis continue to be exempt from Directive 2001/18/EC (2) and are therefore not subject to the strict rules on transgenic...

mehr lesen
IP2’s Christmas Blog

IP2’s Christmas Blog

All I want for Christmas … is cash It's that time of year again, when "Fairytale of New York" and "Last Christmas" fight for the crown, which of the two is once again the most popular Christmas song in Europe. The Pogues' quirky song just happens to have something to...

mehr lesen
Brain organoids – Can thinking tissue be patentable

Brain organoids – Can thinking tissue be patentable

Admittedly, this question is initially hypothetical Brain organoids are 3D tissue models that replicate one or more regions of the brain. They can overcome the shortcomings of conventional post-mortem brain tissue and animal brain tissue models and provide clinically...

mehr lesen
Can AI be inventor?

Can AI be inventor?

..From KI as a tool to KI as an inventor The German software pioneer SAP defines artificial intelligence as a generic term for applications in which machines perform human-like intelligence services. This includes machine learning, natural language processing (NLP)...

mehr lesen
Curevac versus Biontech

Curevac versus Biontech

What we know... As various print media reported unanimously this week, the Tübingen-based biotech company CureVac has filed a patent infringement suit against the Corona vaccine manufacturer BioNTech SE and two subsidiaries at the Düsseldorf Regional Court. CureVac...

mehr lesen
From Russia with(out) love

From Russia with(out) love

Russia dismisses patent protection for patentees from “unfriendly” countries By decree, Russia has de facto abolished the protection of patents whose owners are registered in, do business in, or have citizenship of so-called “unfriendly” countries. In concrete terms,...

mehr lesen
No exclusivity for delicate baby skin

No exclusivity for delicate baby skin

The fact that it is difficult to protect one's packaging from imitation without enjoying trademark protection in return was once again demonstrated this week by a decision of the Düsseldorf Regional Court: A case of unfair competition? The Soest-based company Bübchen...

mehr lesen

Our Authors

Bernd Fabry is founder and CEO of IP2. He is a qualified German and European Patent and Trademark Attorney. He has more than 25 years company experience as Head of IP departments. 

Dr. Bernd Fabry - CEO

We are pleased that our Scientific Adviser, Dr. Martin Fabry from the University of Cambridge, will now report regularly on new developments in this exciting field.

Dr. Martin Fabry - Scientific Advisor

Subscribe to our newsletter!

Never miss the newest blog post or important information about patents and laws